MAPT and Alzheimer disease: Alzheimer's disease (AD) is a progressive neurodegenerative disorder that was first histologically characterized by neuron and synapse loss, reactive gliosis, and misfolded aggregated proteins, including extracellular amyloid beta (Aβ) plaques and intracellular neurofibrillary tangles composed of primarily hyperphosphorylated tau [1].